Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Triamcinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for triamcinolone acetonide and what is the scope of triamcinolone acetonide patent protection?

Triamcinolone acetonide
is the generic ingredient in twenty-four branded drugs marketed by Mylan Pharms Inc, Apothecon, Delcor Asset Corp, Taro, Parnell, Perrigo Israel, Ranbaxy Labs Ltd, Teligent Pharma Inc, Teva, Pharmafair, Akorn, Solvay, Perrigo New York, Alpharma Us Pharms, Astellas, Abbvie, Glenmark Pharms Ltd, Allergan, Lupin Atlantis, Watson Labs, Ivax Pharms, G And W Labs Inc, Ambix, Crown Labs, Novartis Pharms Corp, Wockhardt Eu Operatn, Wockhardt, Sandoz Inc, Fougera Pharms, Sanofi Aventis Us, Vintage, Lyne, Topiderm, Perrigo Uk Finco, Pharmaderm, Morton Grove, Savage Labs, G And W Labs, Cmp Pharma Inc, and Actavis Mid Atlantic, and is included in one hundred and seventeen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has fifty-six patent family members in thirty-two countries.

There are fifty drug master file entries for triamcinolone acetonide. Eighty-two suppliers are listed for this compound.

Summary for Generic Name: triamcinolone acetonide

Tradenames:24
Patents:7
Applicants:40
NDAs:117
Drug Master File Entries: see list50
Suppliers / Packagers: see list82
Bulk Api Vendors: see list49
Clinical Trials: see list113
Patent Applications: see list6,040
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:triamcinolone acetonide at DailyMed

Pharmacology for Ingredient: triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL086277-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
OINTMENT;TOPICAL088780-001Oct 1, 1984DISCNNoNo► Subscribe► Subscribe
Taro
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL040038-001Oct 26, 1994DISCNNoNo► Subscribe► Subscribe
Perrigo New York
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL086413-001Approved Prior to Jan 1, 1982ATRXNoNo► Subscribe► Subscribe
Perrigo New York
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL086414-001Approved Prior to Jan 1, 1982ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot